Treatment of allergic rhinitis using mobile technology with real‐world data: The MASK observational pilot study
Open Access
Abstract
Background: Large observational implementation studies are needed to triangulate the findings from randomized control trials as they reflect “real‐world” everyday practice. In a pilot study, we attempted to provide additional and complementary insights on the real‐life treatment of allergic rhinitis (AR) using mobile technology.Methods: A mobile phone app (Allergy Diary, freely available in Google Play and Apple App stores) collects the data of daily visual analog scales (VAS) for (i) overall allergic symptoms, (ii) nasal, ocular, and asthma symptoms, (iii) work, as well as (iv) medication use using a treatment scroll list including all medications (prescribed and over the counter (OTC)) for rhinitis customized for 15 countries.Results: A total of 2871 users filled in 17 091 days of VAS in 2015 and 2016. Medications were reported for 9634 days. The assessment of days appeared to be more informative than the course of the treatment as, in real life, patients do not necessarily use treatment on a daily basis; rather, they appear to increase treatment use with the loss of symptom control. The Allergy Diary allowed differentiation between treatments within or between classes (intranasal corticosteroid use containing medications and oral H1‐antihistamines). The control of days differed between no [best control], single, or multiple treatments (worst control).Conclusions: This study confirms the usefulness of the Allergy Diary in accessing and assessing everyday use and practice in AR. This pilot observational study uses a very simple assessment (VAS) on a mobile phone, shows novel findings, and generates new hypotheses.Keywords
This publication has 28 references indexed in Scilit:
- Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK‐rhinitis studyAllergy, 2017
- ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleClinical and Translational Allergy, 2016
- Current controversies and challenges in allergic rhinitis managementExpert Review of Clinical Immunology, 2015
- MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementationAllergy, 2015
- The European Innovation Partnership on Active and Healthy Ageing: The European geriatric medicine introduces the EIP on AHA columnEuropean Geriatric Medicine, 2014
- Integrated care pathways for airway diseases (AIRWAYS-ICPs)European Respiratory Journal, 2014
- How representative are clinical study patients with allergic rhinitis in primary care?Journal of Allergy and Clinical Immunology, 2011
- Methods in Epidemiology: Observational Study DesignsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Observational studies: going beyond the boundaries of randomized controlled trialsDiabetes Research and Clinical Practice, 2010
- External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?Thorax, 2007